|Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies|
A Modabbernia, S Taslimi, E Brietzke, M Ashrafi
Biological psychiatry 74 (1), 15-25, 2013
|Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses|
A Modabbernia, E Velthorst, A Reichenberg
Molecular autism 8 (1), 13, 2017
|Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study|
SH Abbasi, F Hosseini, A Modabbernia, M Ashrafi, S Akhondzadeh
Journal of affective disorders 141 (2-3), 308-314, 2012
|Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial|
M Shahidi, A Mojtahed, A Modabbernia, M Mojtahed, A Shafiabady, ...
International journal of geriatric psychiatry 26 (3), 322-327, 2011
|Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study|
A Ghaleiha, N Entezari, A Modabbernia, B Najand, N Askari, M Tabrizi, ...
Journal of psychiatric research 47 (2), 175-180, 2013
|Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial|
A Modabbernia, H Sohrabi, AA Nasehi, F Raisi, S Saroukhani, A Jamshidi, ...
Psychopharmacology 223 (4), 381-388, 2012
|Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study|
L Kashani, F Raisi, S Saroukhani, H Sohrabi, A Modabbernia, AA Nasehi, ...
Human Psychopharmacology: Clinical and Experimental 28 (1), 54-60, 2013
|Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia|
A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ...
CNS drugs 27 (1), 57-65, 2013
|Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania|
Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ...
Journal of affective disorders 129 (1-3), 327-331, 2011
|Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial|
K Sepanjnia, A Modabbernia, M Ashrafi, MJ Modabbernia, ...
Neuropsychopharmacology 37 (9), 2093-2100, 2012
|Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial|
M Asadabadi, MR Mohammadi, A Ghanizadeh, A Modabbernia, M Ashrafi, ...
Psychopharmacology 225 (1), 51-59, 2013
|Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study|
MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ...
Psychiatry Research 215 (3), 540-546, 2014
|Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.|
D Khajavi, M Farokhnia, A Modabbernia, M Ashrafi, SH Abbasi, M Tabrizi, ...
The Journal of clinical psychiatry 73 (11), 1428, 2012
|Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study|
A Modabbernia, P Heidari, R Soleimani, A Sobhani, ZA Roshan, S Taslimi, ...
Journal of psychiatric research 53, 133-140, 2014
|Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome …|
L Kashani, T Omidvar, B Farazmand, A Modabbernia, F Ramzanzadeh, ...
Psychoneuroendocrinology 38 (6), 767-776, 2013
|Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies|
S Taslimi, A Modabbernia, S Amin-Hanjani, FG Barker, RL Macdonald
Neurology 86 (21), 1984-1991, 2016
|Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study|
F Rezaei, M Mohammad-karimi, S Seddighi, A Modabbernia, M Ashrafi, ...
Journal of clinical psychopharmacology 33 (3), 336-342, 2013
|Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder|
N Askari, M Moin, M Sanati, M Tajdini, A Modabbernia, B Najand, S Salimi, ...
CNS drugs 26 (10), 883-892, 2012
|Prevalence of depressive disorders in Rasht, Iran: A community based study|
MJ Modabernia, HS Tehrani, M Fallahi, M Shirazi, AH Modabbernia
Clinical practice and epidemiology in mental health 4 (1), 20, 2008
|Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review|
A Modabbernia, H Poustchi, R Malekzadeh
Hepatitis monthly 13 (1), 2013